Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Decomac IV 75mg Injection

Prescription Icon
Prescription Required

Marketer

Amross Lifescience

Salt Composition

Diclofenac (75mg)

Overview Decomac IV 75mg Injection

Injex 75mg, an intravenous pain medication, alleviates pain, inflammation, and stiffness associated with conditions such as rheumatoid and osteoarthritis, and acute musculoskeletal trauma. Administered intravenously by a medical professional only – self-injection is strictly prohibited – it's indicated when oral medication is infeasible. Patients with a history of cardiovascular events (heart disease or stroke) should inform their physician. Report any injection site reactions (pain, swelling, redness) immediately. Common side effects include nausea, vomiting, headache, and local injection site reactions. Prolonged use necessitates regular monitoring of kidney and liver function, along with blood component levels. Extended therapy carries potential risks, including gastrointestinal bleeding and renal complications.

Uses of Decomac IV 75mg Injection

Alleviation of discomfort

Major Benefits of Decomac IV 75mg Injection:

This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.

Common Side effects of Decomac IV 75mg Injection:

  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Flatulence
  • Edema (swelling)
  • Nausea
  • Headache
  • Dizziness

How to use Decomac IV 75mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Decomac IV 75mg Injection works:

Decomac IV 75mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated redness and swelling.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Decomac IV 75mg Injection concurrently with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Decomac IV 75mg Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits clearly outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Decomac IV 75mg Injection to breastfeeding individuals may pose a risk. Available evidence from human studies indicates potential transfer to breast milk, with the possibility of infant harm.

DrivingDrivingUNSAFE

Administering Decomac IV 75mg Injection may impair driving ability due to potential adverse reactions.

KidneyKidneyCAUTION

Administering Decomac IV 75mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification for Decomac IV 75mg Injection might be necessary. Physician consultation is advised.

LiverLiverCAUTION

For individuals with hepatic impairment, administration of Decomac IV 75mg Injection requires careful monitoring. Dosage modification of Decomac IV 75mg Injection might be necessary. Physician consultation is advised.

What if you forget to take Decomac IV 75mg Injection :

Omit a dose of Decomac IV 75mg Injection? Seek your physician's advice.

Facts to Know About Decomac IV 75mg Injection

LabelValue
Type of Compound Compound derived from phenylacetic acid
Potential for Dependence None.
Type of Medication Pain relievers

FAQs on Decomac IV 75mg Injection

Administering Decomac IV 75mg Injection requires a qualified healthcare provider. The injection may be delivered intramuscularly (ideally into the gluteal muscle), subcutaneously, or intravenously as a bolus—infusion is contraindicated. The prescribed dosage must not be exceeded, and treatment should not continue beyond two days.
Decomac IV 75mg Injection carries an elevated risk of heart attack or stroke, particularly with higher doses or prolonged use. This medication also presents a risk of stomach and intestinal ulcers, bleeding, or perforation, potentially fatal and occurring without prior warning at any point during treatment. Immediate medical attention is crucial should any of these complications arise.
Intravenous Decomac, administered at a 75mg dose, provides relief from pain and inflammation. Its applications include the management of pain associated with sprains, strains, and other traumatic injuries. This medication also offers benefit in treating diverse arthritic conditions, gout, and post-surgical pain and inflammation.
Prolonged administration and substantial dosages of Decomac IV 75mg Injection can potentially induce renal complications, manifesting as proteinuria, hematuria, or dysuria. Individuals with pre-existing conditions increasing renal vulnerability—including dehydration, cardiac insufficiency, compromised renal function, hypertension, advanced age, or concurrent use of diuretics or nephrotoxic medications—are at heightened risk. Therefore, close monitoring of kidney function is advised for these patients.
Administering Decomac IV 75mg Injection may induce somnolence, vertigo, lassitude, and visual impairment. These side effects are infrequent and not universally experienced. Patients exhibiting such symptoms should refrain from driving or operating complex equipment.
Administering Decomac IV 75mg Injection is contraindicated in the final trimester of pregnancy due to potential fetal harm. This medication may also induce preterm labor. Therefore, its use should also be avoided during the first six months of pregnancy. In exceptional circumstances, a physician might prescribe Decomac IV 75mg Injection to pregnant patients only when the potential benefits clearly surpass the associated risks. Always seek medical guidance before using this injection during pregnancy.
Decomac IV 75mg Injection is not a recreational drug; it does not produce euphoria and is not associated with addictive properties or dependence, either physical or psychological. Nevertheless, if you experience adverse effects, seek medical attention.
Decomac IV 75mg Injection is not a narcotic analgesic; it's classified as a non-steroidal anti-inflammatory drug (NSAID).
Decomac IV 75mg Injection
197
MRP 240
17% off